Prosecution Insights
Prosecution Insights
20 pending office actions • 17 art units • 19 examiners • 0 of 20 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (5%) |
| §103 only | 8 (40%) |
| §112 only | 3 (15%) |
| No statute on record | 8 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IVICH, FERNANDO NMN | 2 | 42.9% | +77.9% |
| AKAR, SERKAN | 1 | 65.6% | +31.4% |
| TAYLOR, LIA ELAN | 1 | 64.0% | +28.2% |
| PIPIC, ALMA | 1 | 54.5% | +55.6% |
| COUNTS, GARY W | 1 | 58.9% | +29.3% |
| WILKINS III, HARRY D | 1 | 62.5% | +18.4% |
| FONTAINHAS, AURORA M | 1 | 37.5% | +48.0% |
| RUMMEL, JULIA L | 1 | 34.5% | +52.2% |
| LIU, SUE XU | 1 | 20.6% | +15.4% |
| GONZALES, JOSEPHINE MARIA | 1 | 29.8% | +42.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18224345 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | LIU, SUE XU | 168d overdue |
| 18557941 | Biomarkers for Neurodegenerative Disease | COUNTS, GARY W | 13d |
| 18137449 | METHODS OF USING PULMONARY CELLS FOR TRANSPLANTATION AND INDUCTION OF TOLERANCE | GONZALES, JOSEPHINE MARIA | 27d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18224345 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | LIU, SUE XU | 168d overdue |
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | IVICH, FERNANDO NMN | 168d overdue |
| 18106903 | TREATMENT OF AN ISCHEMIC HEART DISEASE | TAYLOR, LIA ELAN | 121d overdue |
| 17637098 | SCALED-UP METHODS FOR PURIFYING ANTIBODIES | IVICH, FERNANDO NMN | 44d overdue |
| 18262732 | A NONCOVALENT HYBRID COMPRISING CARBON NANOTUBES (CNT) AND AROMATIC COMPOUNDS AND USES THEREOF | RUMMEL, JULIA L | 36d overdue |
| 18424973 | SURFACE TREATMENT OF CONTACT LENS AND TREATMENT OF OCULAR DISCOMFORT BY WATER SOLUBLE POLYMERS AND LIPIDS/LIPOSOMES | PIPIC, ALMA | 22d overdue |
| 18701580 | SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA | AKAR, SERKAN | 10d overdue |
| 18557941 | Biomarkers for Neurodegenerative Disease | COUNTS, GARY W | 13d |
| Art Unit | Apps |
|---|---|
| 1678 | 3 |
| 1641 | 2 |
| 3797 | 1 |
| 1617 | 1 |
| 1794 | 1 |
| 1675 | 1 |
| 1784 | 1 |
| 1616 | 1 |
| 1631 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18701580 | SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA | AKAR, SERKAN | 3797 | §103 | Non-Final OA | 10d overdue | Pending | Apr 15, 2024 |
| 18106903 | TREATMENT OF AN ISCHEMIC HEART DISEASE | TAYLOR, LIA ELAN | 1641 | §112 | Final Rejection | 121d overdue | Pending | Mar 08, 2024 |
| 18424973 | SURFACE TREATMENT OF CONTACT LENS AND TREATMENT OF OCULAR DISCOMFORT BY WATER SOLUBLE POLYMERS AND LIPIDS/LIPOSOMES | PIPIC, ALMA | 1617 | Other | Non-Final OA | 22d overdue | Pending | Jan 29, 2024 |
| 18557941 | Biomarkers for Neurodegenerative Disease | COUNTS, GARY W | 1678 | §101 | Non-Final OA | 13d | Pending | Oct 29, 2023 |
| 18489882 | STIRRING-FREE SCALABLE ELECTROSYNTHESIS ENABLED BY ALTERNATING CURRENT | WILKINS III, HARRY D | 1794 | §103 | Final Rejection | 46d | Pending | Oct 19, 2023 |
| 18360222 | Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease | FONTAINHAS, AURORA M | 1675 | Other | Non-Final OA | 20d | Pending | Jul 27, 2023 |
| 18262732 | A NONCOVALENT HYBRID COMPRISING CARBON NANOTUBES (CNT) AND AROMATIC COMPOUNDS AND USES THEREOF | RUMMEL, JULIA L | 1784 | §103 | Non-Final OA | 36d overdue | Pending | Jul 25, 2023 |
| 18224345 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | LIU, SUE XU | 1616 | — | Final Rejection | 168d overdue | Pending | Jul 20, 2023 |
| 18137449 | METHODS OF USING PULMONARY CELLS FOR TRANSPLANTATION AND INDUCTION OF TOLERANCE | GONZALES, JOSEPHINE MARIA | 1631 | Other | Non-Final OA | 27d | Pending | Apr 21, 2023 |
| 18027168 | METHOD FOR MODULATING WEIGHT | ISMAIL, REHANA | 1625 | §103 | Non-Final OA | 57d | Pending | Mar 20, 2023 |
| 17999934 | QUANTUM SIMULATION WITH TRAPPED IONS IN A GRADIENT FIELD | SHALABY, AHMAD HUSSAM | 2187 | §103 | Non-Final OA | 5d overdue | Pending | Nov 28, 2022 |
| 18048873 | SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS | CELESTINE, NYROBI I | 3798 | §103 | Non-Final OA | 2d overdue | Pending | Oct 24, 2022 |
| 17958516 | METHODS OF DIAGNOSING CANCER AND PREDICTING RESPONSIVENESS TO THERAPY | SWITZER, JULIET CAROLINE | 1682 | §112 | Non-Final OA | 72d | Pending | Oct 03, 2022 |
| 17915500 | VARIANTS OF BETA-GLUCOCEREBROSIDASE FOR USE IN TREATING GAUCHER DISEASE | XU, QING | 1656 | §112 | Non-Final OA | 15d | Pending | Sep 29, 2022 |
| 17798415 | CHONDROITINASE ABC MUTANTS AND METHODS OF MANUFACTURE AND USE THEREOF | RAGHU, GANAPATHIRAM | 1652 | §103 | Final Rejection | 96d overdue | Pending | Aug 09, 2022 |
| 17870876 | MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES | LUNDE, GRACE HENRY | 1641 | Other | Final Rejection | — | Pending | Jul 22, 2022 |
| 17702880 | ASSEMBLY OF PROTEIN COMPLEXES ON A CHIP | GROSS, CHRISTOPHER M | 1684 | §103 | Non-Final OA | 42d overdue | Pending | Mar 24, 2022 |
| 17637098 | SCALED-UP METHODS FOR PURIFYING ANTIBODIES | IVICH, FERNANDO NMN | 1678 | Other | Final Rejection | 44d overdue | Pending | Feb 22, 2022 |
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | IVICH, FERNANDO NMN | 1678 | — | Final Rejection | 168d overdue | Pending | Nov 29, 2021 |
| 15516407 | LIPOSOMES-CONTAINING ANTIFOULING COMPOSITIONS AND USES THEREOF | WESTERBERG, NISSA M | 1618 | Other | Non-Final OA | 87d overdue | Pending | Apr 02, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial